|
| | HB0739 Enrolled | | LRB102 02799 CPF 12807 b |
|
|
1 | | AN ACT concerning health.
|
2 | | Be it enacted by the People of the State of Illinois,
|
3 | | represented in the General Assembly:
|
4 | | Section 5. The Illinois Sexually Transmissible Disease |
5 | | Control Act is amended by changing Section 6 as follows:
|
6 | | (410 ILCS 325/6) (from Ch. 111 1/2, par. 7406)
|
7 | | Sec. 6. Physical examination and treatment.
|
8 | | (a) Subject to the provisions of subsection (c) of this |
9 | | Section, the
Department and its authorized representatives may |
10 | | examine or cause to be
examined persons reasonably believed to |
11 | | be infected with or to have been
exposed to a sexually |
12 | | transmissible disease.
|
13 | | (b) Subject to the provisions of subsection (c) of this |
14 | | Section, persons
with a sexually transmissible disease shall |
15 | | report for complete treatment to a
physician licensed under |
16 | | the provisions of the Medical Practice Act of
1987, or shall |
17 | | submit to treatment at a facility provided by a local health
|
18 | | authority or other public facility, as the Department shall |
19 | | require by rule or
regulation until the disease is |
20 | | noncommunicable or the Department determines
that the person |
21 | | does not present a real and present danger to the public
|
22 | | health. This subsection (b) shall not be construed to require |
23 | | the Department
or local health authorities to pay for or |
|
| | HB0739 Enrolled | - 2 - | LRB102 02799 CPF 12807 b |
|
|
1 | | provide such treatment.
|
2 | | (c) No person shall be apprehended, examined or treated |
3 | | for a sexually
transmissible disease against his will, under |
4 | | the provisions of this Act,
except upon the presentation of a |
5 | | warrant duly authorized by a court of
competent jurisdiction. |
6 | | In requesting the issuance of such a warrant the
Department |
7 | | shall show by a preponderance of evidence that the person is
|
8 | | infectious and that a real and present danger to the public |
9 | | health and
welfare exists unless such warrant is issued and |
10 | | shall show that all other
reasonable means of obtaining |
11 | | compliance have been exhausted and that no
other less |
12 | | restrictive alternative is available. The court shall require
|
13 | | any proceedings authorized by this subsection (c) to be |
14 | | conducted in
camera. A record shall be made of such |
15 | | proceedings but shall be sealed,
impounded and preserved in |
16 | | the records of the court, to be made available
to the reviewing |
17 | | court in the event of an appeal.
|
18 | | (d) Any person who knowingly or maliciously disseminates |
19 | | any false
information or report concerning the existence of |
20 | | any sexually
transmissible disease under this Section is |
21 | | guilty of a Class A misdemeanor.
|
22 | | (e) Taking into account the recommendations of the U.S. |
23 | | Centers for Disease Control and Prevention and other |
24 | | nationally recognized medical authorities, the Department |
25 | | shall provide information and technical assistance as |
26 | | appropriate to health care professionals who provide expedited |
|
| | HB0739 Enrolled | - 3 - | LRB102 02799 CPF 12807 b |
|
|
1 | | partner therapy services for persons with sexually |
2 | | transmissible diseases. |
3 | | (1) Notwithstanding any other provision of law, a |
4 | | health care professional who makes a clinical diagnosis of |
5 | | chlamydia , or gonorrhea , or trichomoniasis may prescribe, |
6 | | dispense, furnish, or otherwise provide prescription |
7 | | antibiotic drugs to the infected person's sexual partner |
8 | | or partners for the treatment of the sexually |
9 | | transmissible disease without physical examination of the |
10 | | partner or partners, if in the judgment of the health care |
11 | | professional the partner is unlikely or unable to present |
12 | | for comprehensive healthcare, including evaluation, |
13 | | testing, and treatment for sexually transmissible |
14 | | diseases. Expedited partner therapy shall be limited to |
15 | | partners who may have been exposed to a sexually |
16 | | transmissible disease within the previous 60 days, if the |
17 | | patient is able to contact the partner. |
18 | | (2) Health care professionals who provide expedited |
19 | | partner therapy shall comply with Sections 4 and 5 of the |
20 | | Illinois Sexually Transmissible Disease Control Act. |
21 | | (3) Health care professionals who provide expedited |
22 | | partner therapy shall provide counseling for the patient |
23 | | and written materials provided by the Department to be |
24 | | given by the patient to the partner or partners that |
25 | | include at a minimum the following: |
26 | | (A) a warning that a woman who is pregnant or might |
|
| | HB0739 Enrolled | - 4 - | LRB102 02799 CPF 12807 b |
|
|
1 | | be pregnant must not take certain antibiotics and must |
2 | | immediately contact a health care professional for an |
3 | | examination, and a recommendation for such an |
4 | | examination; |
5 | | (B) information about the antibiotic and dosage |
6 | | provided or prescribed; clear and explicit allergy and |
7 | | side effect warnings, including a warning that a |
8 | | partner who has a history of allergy to the antibiotic |
9 | | or the pharmaceutical class of antibiotic must not |
10 | | take the antibiotic and must be immediately examined |
11 | | by a health care professional, and a recommendation |
12 | | for such an examination; |
13 | | (C) information about the treatment and prevention |
14 | | of sexually transmissible diseases; |
15 | | (D) the requirement of abstinence until a period |
16 | | of time after treatment to prevent infecting others; |
17 | | (E) notification of the importance of the partner |
18 | | or partners of the patient to receive examination and |
19 | | testing for HIV and other sexually transmissible |
20 | | diseases, and available resources; |
21 | | (F) notification of the risk to self, others, and |
22 | | the public health if the sexually transmissible |
23 | | disease is not completely and successfully treated; |
24 | | (G) the responsibility of the partner or partners |
25 | | to inform his or her sex partner or partners of the |
26 | | risk of sexually transmissible disease and the |
|
| | HB0739 Enrolled | - 5 - | LRB102 02799 CPF 12807 b |
|
|
1 | | importance of prompt examination and treatment; and |
2 | | (H) other information as deemed necessary by the |
3 | | Department. |
4 | | (4) The Department shall develop and disseminate in |
5 | | electronic and other formats the following written |
6 | | materials: |
7 | | (A) informational materials for partners, as |
8 | | required in item (3) of this subsection (e); |
9 | | (B) informational materials for persons who are |
10 | | repeatedly diagnosed with sexually transmissible |
11 | | diseases; and |
12 | | (C) guidance for health care professionals on the |
13 | | safe and effective provision of expedited partner |
14 | | therapy. |
15 | | The Department may offer educational programs about |
16 | | expedited partner therapy for health care professionals |
17 | | and pharmacists licensed under the Pharmacy Practice Act. |
18 | | (5) A health care professional prescribing, |
19 | | dispensing, furnishing, or otherwise providing in good |
20 | | faith without fee or compensation prescription antibiotics |
21 | | to partners under this subsection (e) and providing |
22 | | counseling and written materials as required by item (3) |
23 | | of this subsection (e) shall not be subject to civil or |
24 | | professional liability, except for willful and wanton |
25 | | misconduct. A health care professional shall not be |
26 | | subject to civil or professional liability for choosing |
|
| | HB0739 Enrolled | - 6 - | LRB102 02799 CPF 12807 b |
|
|
1 | | not to provide expedited partner therapy. |
2 | | (6) A pharmacist or pharmacy shall not be subject to |
3 | | civil or professional liability for choosing not to fill a |
4 | | prescription that would cause the pharmacist or pharmacy |
5 | | to violate any provision of the Pharmacy Practice Act, |
6 | | including the definition of "prescription" set forth in |
7 | | subsection (e) of Section 3 of the Pharmacy Practice Act |
8 | | or the definition of "drug regimen review" set forth in |
9 | | subsection (y) of Section 3 of the Pharmacy Practice Act. |
10 | | (Source: P.A. 96-613, eff. 1-1-10.)
|